Bloomberg / Contributor / Getty Images Key Takeaways The S&P 500 fell 0.1% on Friday, May 9, 2025 as investors waited for fresh developments on tariffs ahead of a weekend meeting between U.S. and Chinese officials. Shares of Insulet surged after the insulin pump maker lifted its full-year revenue outlook and analysts lifted their price targets for the stock. Expedia shares tumbled after the company lowered its full-year outlook amid weak U.S. travel demand. Major U.S. equities indexes pulled back from their early gains Friday as investors wait for new developments on tariffs ahead of a weekend meeting between U.S. and Chinese officials. The S&P 500 finished lower by 0.1% as the benchmark index broke a two-day winning streak to end the week lower by about 0.5%. The Dow Jones Industrial Average was down about 0.3% Friday, while the Nasdaq was unchanged. Both indexes also finished the week in negative territory. Shares of insulin pump maker Insulet (PODD) surged by more than 20% Friday to pace the S&P 500, after the company reported stronger-than-anticipated quarterly results and lifted its full-year revenue outlook. Jefferies analysts lifted their price target on the stock to $360 from $350, suggesting significant upside from the stock's close near $311 Friday. Microchip Technology (MCHP) jumped by 12.6% after several analysts raised their price targets for the stock on the chipmaker's better-than-expected outlook. While Microchip’s fourth-quarter sales fell 27% year-over-year, analysts were expecting a steeper drop. Tesla (TSLA) shares jumped 4.7% to post gains for the third straight week amid optimism about new U.S. trade deals. The surge came after a weak start to the week following a string of reports on declining sales in Europe and China. Akamai Technologies (AKAM) stock declined more than 10% after Scotiabank lowered its price target on the cybersecurity and cloud computing company to $105 from $107, with its shares closing just above $76 on Friday. Expedia Group (EXPE) shares tumbled nearly 8% after the travel booking service delivered worse-than-expected first quarter results and lowered its full-year outlook amid weak U.S. travel demand. CEO Ariane Gorin said the company managed to grow bookings and revenue "despite weaker than expected demand in the U.S." Shares of TKO Group Holdings (TKO), the parent of World Wrestling Entertainment and Ultimate Fighting Championship, fell 5.5% after earnings missed analysts' expectations. The company lifted its full-year revenue forecast. Read the original article on Investopedia View Comments
S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...